Is ablation an option vs surgery

November 4, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Ablation vs. Surgery for Recurrent Anal Cancer

Based on Hillel's clinical summary, the document indicates that his care team is evaluating "salvage surgery vs. additional radiation" as treatment options for his recurrent disease. However, the document does not specifically mention ablation as a treatment consideration.

What the Document Shows:

According to the clinical summary, Hillel has:

  • Recurrent squamous cell carcinoma in the anal canal (confirmed October 2025)
  • A 4x2 cm ulcerative mass extending 5 cm into the rectum
  • Progressive disease with intense metabolic activity on PET/CT
  • Severe symptoms including anal pain and bleeding

The recommendations note that the multidisciplinary tumor board should discuss "salvage treatment planning" and evaluate candidacy for salvage surgery versus additional radiation.

Important Next Steps:

This is a question best addressed directly with Hillel's oncology and colorectal surgery team, as they can:

  • Evaluate whether ablation techniques (like radiofrequency or cryoablation) might be appropriate given his specific tumor characteristics
  • Compare ablation against surgery and radiation options
  • Consider his BRCA2 and ATM mutations, which may influence treatment decisions

According to NCCN Guidelines for Anal Carcinoma, treatment decisions for recurrent disease should involve multidisciplinary evaluation, which is exactly what the document recommends for Hillel's case.

Would you like information about what salvage treatment options are typically considered for recurrent anal cancer?

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2